XML 61 R37.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Weighted-average assumptions used to estimate fair value of restricted stock units Inputs and assumptions used to calculate the fair value are shown in the table below. The fair value of these RSUs is expensed over the vesting period using the straight-line method or using the graded vesting method when an employee becomes eligible to retain the award at retirement.
Three Months Ended March 31,20222021
Fair value per stock award$141.95 $171.63 
Grant date stock price$114.52 $141.59 
Assumptions:
Aptar's stock price expected volatility20.20 %21.40 %
Expected average volatility of peer companies41.70 %50.00 %
Correlation assumption41.20 %58.10 %
Risk-free interest rate2.04 %0.32 %
Dividend yield assumption1.33 %1.02 %
Summary of restricted stock unit activity
A summary of RSU activity as of March 31, 2022 and changes during the three month period then ended is presented below:
Time-Based RSUsPerformance-Based RSUs
UnitsWeighted Average
Grant-Date Fair Value		UnitsWeighted Average
Grant-Date Fair Value
Nonvested at January 1, 2022485,479 $108.73 650,553 $111.04 
Granted176,096 112.64 204,377 127.95 
Vested(130,763)102.60 — — 
Forfeited(5,206)110.59 (8,088)119.16 
Nonvested at March 31, 2022525,606 $111.43 846,842 $115.05 
Schedule of compensation expense, fair value, and intrinsic value related to RSU's
Three Months Ended March 31,20222021
Compensation expense$13,362 $11,262 
Fair value of units vested12,361 19,116 
Intrinsic value of units vested15,291 25,699 
Summary of option activity A summary of option activity under our stock plans during the three months ended March 31, 2022 is presented below:
Stock Awards PlansDirector Stock Option Plans
OptionsWeighted Average
Exercise Price		OptionsWeighted Average
Exercise Price
Outstanding, January 1, 20223,072,503 $71.99 51,700 $63.91 
Exercised(61,775)59.68 — — 
Forfeited or expired(400)51.80 — — 
Outstanding at March 31, 20223,010,328 $72.24 51,700 $63.91 
Exercisable at March 31, 20223,010,328 $72.24 51,700 $63.91 
Weighted-Average Remaining Contractual Term (Years):
Outstanding at March 31, 20223.91.8
Exercisable at March 31, 20223.91.8
Aggregate Intrinsic Value:
Outstanding at March 31, 2022$136,239 $2,770 
Exercisable at March 31, 2022$136,239 $2,770 
Intrinsic Value of Options Exercised During the Three Months Ended:
March 31, 2022$3,780 $— 
March 31, 2021$37,454 $2,474 
Schedule of compensation expense, and fair value related to options
Three Months Ended March 31,2021
Compensation expense (included in SG&A)$185 
Compensation expense (included in Cost of sales)42 
Compensation expense, Total$227 
Compensation expense, net of tax174 
Grant date fair value of options vested2,421